Scientists like “This Drug” from the 70’s...

Important information about your income
This is an Advertisement from our trusted sponsors

"This 70's Drug" Makes a Medical Comeback...

It's amazing how a drug from the 60's and 70's can make such a comeback.

But check this out…

These drugs are actually helping to treat various mental health disorders, including anxiety, depression, pain, and schizophrenia.

And the company behind these innovations is primed to potentially generate big returns in the medicine space.

This market is set to BOOM…

Johns Hopkins has already opened a center dedicated entirely to these types of medicines, for which it received over $17 million in donations.

Even smart investors like the legendary Peter Thiel — are scrambling to stake a claim in this space.

And this company has the edge.

Which is why we compiled a full report so that you can see why this space could be a great investment in 2021.

Click here for the exclusive details.

The Team @ MINDCURE

P.S.This company may not stay at its current price for long… get ahead of the competition and grab your full report here.

 


DISCLAIMERS - THIS IS A PAID ADVERTISEMENT.

This website / media webpage is a paid advertisement, not a recommendation nor an offer to buy or sell securities. Our business model is to be financially compensated to market and promote public companies. By reading our website / media webpage you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature and are therefore are unqualified to give investment recommendations. Always do your own research and consult with a licensed investment professional before investing. This communication is never to be used as the basis for making investment decisions and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Conduct your own research. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor's, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our website / media webpage.

IRPub LLC has received Ten Thousand Dollars paid by a third party, Digitonic Ltd., for and on behalf of MINDCURE (CSE:MCUR | OTC:MCURF) for brand awareness, marketing tion and investor education marketing for a period of 5 Days. IR Pub has not received any shares nor owns any shares of MINDCURE (CSE:MCUR | OTC:MCURF) For a full disclaimer | disclosure please click here.

This communication is a paid advertisement and is not a recommendation to buy or sell securities. IRPub LLThis communication is a paid advertisement and is not a recommendation to buy or sell securities. IRPub LLC, and its owners, managers, employees, and assigns (collectively "the Company") has been paid by the profiled company or a third party to disseminate this communication. In this case the Company has been paid by Digitonic Ltd., for and on behalf of MINDCURE (CSE:MCUR | OTC:MCURF), Ten Thousand US dollars for marketing services for a period of 5 days. To conduct investor relations advertising, marketing and publicly disseminate information not limited to our Websites, Email, SMS, Push Notifications, Influencers, Social Media Postings, Ticker Tags, Press Releases, Online Interviews, Podcasts, Videos, Audio Ads, Banner Ads, Native Ads, Responsive Ads. This compensation is a major conflict with our ability to be unbiased, more specifically: This communication is for entertainment purposes only. Never invest purely based on our communication. Gains mentioned in this article, in our newsletter and on our website may be based on end-of-day or intraday data. We have been compensated by Digitonic Ltd., for and on behalf of MINDCURE (CSE:MCUR | OTC:MCURF) to conduct investor awareness advertising and marketing. Therefore, this communication should be viewed as a commercial advertisement only. The information is collected from public sources, such as the profiled company's website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, IRPub often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers' works are double-checked and verified before publication, and approved by the company that is featured herein, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer's communications regarding the profiled company(s).You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. We have not thoroughly investigated the background of MCURF. The third party, profiled company, or their affiliates may liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Frequently companies profiled in our alerts experience a large increase in volume and share price during the course of investor awareness marketing, which often end as soon as the investor awareness marketing ceases. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our communications and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company's website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct.

NOT AN INVESTMENT ADVISOR. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation.

ALWAYS DO YOUR OWN RESEARCH and consult with a licensed investment professional before making an investment. This communication should not be used as a basis for making any investment. INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing the Company, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

RISK OF INVESTING. Investing is inherently risky. While a potential for rewards exists, by investing, you are putting yourself at risk. You must be aware of the risks and be willing to accept them in order to invest in any type of security. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell securities. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website / media webpage are for entertainment purposes only. Never invest purely based on our featured profiles on Companies. Gains mentioned in our website / media web page may be based on end-of-day or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this message and the product materials are for illustrative purposes only and not to be construed as specific advisory recommendations. All ideas and material presented are entirely those of the author and do not necessarily reflect those of the publisher.

Investor Trade Network Disclaimer

 

7322437 Canada Inc has been retained by IRPub LLC, third party to perform promotional and advertising services for 48 hours, with respect to the company we are profiling or discussing on this website or in this email, and in exchange for such services has received cash compensation of up to $4000. Questions regarding this website may be sent to admin@financialmediamarketing.com

7322437 Canada Inc DOES NOT own any shares of the company mentioned. The principles and employees of 7322437 Canada Inc DO NOT own shares in the company mentioned.

Advertisement: This is a paid advertisement from a 3rd party advertiser, for a product or service that is not offered, recommended or endorsed by us and for which claims have not been independently verified.

Content: All of the content on our website and in our emails is for informational and illustrative purposes only, and should not be construed as an offer, or solicitation of an offer to buy or sell securities. You should always consult with a licensed securities professional before purchasing or selling securities.

7322437 Canada (DBA as Financial Media Marketing) (collectively, the "Company" or "we" used herein) bears no responsibility or control over the content of the advertisement and/or the product or service offered.

Results: Any results shown are strictly hypothetical, and were executed in simulated trading accounts.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

Earnings Disclaimer: Our website, blogs and emails use affiliate and advertising programs for monetization, which means when you open, read, click on ads or links, will result in a commission that is credited to our company.

Compliance: All header and reply-to information is accurate; you may reply directly to this email or send your reply to the physical address or email listed below. Subject lines reflect the content of the email and the email is clearly identified as an advertisement. All opt-outs are automatically honored and managed by the system.

When profiling a specific company / stock or publicly traded company: 7322437 Canada Inc (DBA as Financial Media Marketing) has been retained by a third party to perform promotional and advertising services for a limited time with respect to the company we are profiling or discussing, In exchange for such services we have or will receive cash compensation from the third party. Questions regarding this may be sent to admin@financialmediamarketing.com

Any information regarding a company profiled or discussed on this website or email is provided from public sources. And we make no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed.

Our Principals, employees or affiliates may have a position or effect transactions in the securities described herein (or options thereon) and /or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.

Why are you receiving this email: You are receiving this email because you are subscribed and have requested to receive newsletters from Financial Media Marketing. Please note that Financial Media Marketing will deliver emails to your from several or all of our brands, which will show as different From Names in the emails you receive. You can click here for a list of all our newsletter publications and From Names from which you will receive emails.

Contact: For more information please contact us directly: 7322437 Canada Inc (Financial Media Marketing), 663 Ave Orly, Dorval, Quebec. H9P1G1. Our privacy policy can be found here

If you no longer want to receive any email from us, you can remove yourself from ALL newsletters using this this form.

Your unique contact ID 605b93f542bb0395478b456f. Today is Wednesday.


In order to unsubscribe from this mailing list, please click here

No comments:

Post a Comment